When compared with participants who had neither chronic viral hepatitis nor any use of premixed insulin analogues, the sole presence of any use of premixed insulin analogues had a significantly higher adjusted OR of 1.51 for HCC occurrence. This evidence concerns the gene INS and hepatocellular carcinoma.